Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today.
If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments.
Now in its 5th year, the Canada: Rapid Response 2017 program provides seed funding for high-risk, high-reward, translational research projects on neurodegenerative diseases of aging.
NEW for 2017:
- Projects may request up to $200,000 per project over up to 18 months.
- Applicants may appear in any role on any number of projects.
Goal: To provide funding for novel, high-risk, high-reward, translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.
Funding: A maximum of $200,000 over up to 18 months per project.
Applicant Eligibility: Eligible Principal Applicants must be researchers working in Canada at least 30% of the time at or above the level of Postdoctoral Fellow, and affiliated with a Canada Revenue Agency-qualified donee institution located in Canada.
If the Principal Applicant is not appointed at the institution from which they are applying, they need to apply with a research supervisor (an “Administrative Supervisor”) at or above the level of Assistant Professor or equivalent, with an appointment at the institution from which they are applying.
Applicants may appear in any role on any number of LOIs.
Project Eligibility: Projects must meet two conditions to be eligible,
- Be translational research that helps accelerate the development of therapeutics for neurodegenerative diseases of aging
- Be the development of a therapeutic and/or tool.
|AD-related diseases:||PD-related diseases:|
|o Alzheimer’s disease||o Parkinson’s disease|
|o Frontotemporal dementia||o Progressive supranuclear palsy|
|o Mild cognitive impairment||o Dementia with Lewy bodies|
|o Prodromes to the above||o Multiple systems atrophy|
|o Vascular contributions to the above||o Prodromes to the above|
|o Vascular contributions to the above|
The Institute encourages applicants to contact us at email@example.com or +1 (416) 935-4056 with any questions regarding this program, including whether a potential idea is in scope.
There are two stages to the application process: Letters of Intent and Proposals. An application requires the submission of a Letter of Intent which will be reviewed by our scientific review committee. Applicants with high potential projects will then be invited to submit a Proposal. Instructions for submitting the Proposal will be forwarded to those invited in July 2017.
Parkinson’s and Related Diseases (NOW OPEN)
Alzheimer’s and Related Diseases (NOW OPEN)